The rapid development of vaccines is essential for sustained resistance to new coronaviruses. However, challenges also persist, such as the continued emergence of new variants. Therefore, the developm

As the first oral anti-new coronavirus drug molnupiravir (MK-4482, EIDD-2801), the report attracted attention. This drug candidate from Merck has achieved positive results in the interim analysis of t

The PARP retarder Stepani Veliparib has entered everyone's attention. This type of drug can treat various types of ovarian diseases, and can significantly improve the patient's objective response rate

The European Commission has granted marketing authorisation in the European Union (EU) for Nubeqa® (darolutamide), an oral androgen receptor inhibitor (ARi). The approval is based on Phase III ARAMIS

The U.S. FDA compiles a list of off-patent drugs without an approved generic to encourage the development of copycats. Now, the Chinese authorities are rolling out a similar initiative, only with some

China’s anticorruption authorities have punished 48 officials found responsible for the Changchun Changsheng Life Sciences vaccine scandal that provoked public outrage last summer.